Assertio Holdings, Inc. (ASRT)

0.6593 0.00 (0.00%) USD  |  NASDAQ  |  Dec 24, 12:59
0.67 +0.01 (+1.62%) After-Hours: 13:59
More

Assertio Holdings SG&A Expense (TTM): 63.52M for Sept. 30, 2025

SG&A Expense (TTM) Chart

View SG&A Expense (TTM) for ASRT.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

SG&A Expense (TTM) Range, Past 5 Years

View SG&A Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (TTM) Benchmarks

View SG&A Expense (TTM) Benchmarks
Start Trial
Perspective Therapeutics, Inc. 31.53M
Skye Bioscience, Inc. 16.93M
Theravance Biopharma, Inc. 75.94M
FibroGen, Inc. 28.80M
Myomo, Inc. 32.71M